Stay updated on Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial page
- Check3 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The Back to Top element has been removed.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%
- Check17 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous specific locations for clinical studies related to Tofacitinib, as well as new drug information and related research topics. Notably, the total number of study locations has decreased from 117 to 115.SummaryDifference11%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.3%
Stay in the know with updates to Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 3 Study of CP-690,550 in Rheumatoid Arthritis Clinical Trial page.